Cristina Varas-Lorenzo

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi request reprint Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level
    Cristina Varas-Lorenzo
    Global Epidemiology, Safety and Risk Management, Pfizer Worldwide Development, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 16:366-76. 2007
  2. ncbi request reprint Use of oral corticosteroids and the risk of acute myocardial infarction
    Cristina Varas-Lorenzo
    Pfizer Worldwide Development, Global Epidemiology, Sant Cugat del Vallès, Barcelona, Spain
    Atherosclerosis 192:376-83. 2007
  3. doi request reprint The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada
    Cristina Varas-Lorenzo
    Pfizer, Global Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 18:1016-25. 2009
  4. pmc Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)
    Jordi Castellsague
    RTI Health Solutions, Barcelona, Spain
    Drug Saf 35:1127-46. 2012
  5. doi request reprint Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database
    Cristina Varas-Lorenzo
    RTI Health Solutions, Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 17:842-52. 2008
  6. doi request reprint Stroke risk and NSAIDs: a systematic review of observational studies
    Cristina Varas-Lorenzo
    RTI Health Solutions, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 20:1225-36. 2011
  7. ncbi request reprint Prevalence of glucose metabolism abnormalities and cardiovascular co-morbidity in the US elderly adult population
    Cristina Varas-Lorenzo
    Novartis Farmaceutica S A, Global Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 15:317-26. 2006
  8. ncbi request reprint Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction
    Sonia Hernandez-Diaz
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Basic Clin Pharmacol Toxicol 98:266-74. 2006
  9. ncbi request reprint Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population
    Consuelo Huerta
    Centro Español de Investigación Farmacoepidemiológica, Spanish Centre for Pharmacoepidemiologic Research, Madrid, Spain
    Am J Kidney Dis 45:531-9. 2005
  10. ncbi request reprint Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population
    Luis A Garcia Rodriguez
    Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain
    Circulation 109:3000-6. 2004

Detail Information

Publications11

  1. ncbi request reprint Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level
    Cristina Varas-Lorenzo
    Global Epidemiology, Safety and Risk Management, Pfizer Worldwide Development, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 16:366-76. 2007
    ....
  2. ncbi request reprint Use of oral corticosteroids and the risk of acute myocardial infarction
    Cristina Varas-Lorenzo
    Pfizer Worldwide Development, Global Epidemiology, Sant Cugat del Vallès, Barcelona, Spain
    Atherosclerosis 192:376-83. 2007
    ..A few epidemiological studies suggested an increased coronary heart disease (CHD) risk with high doses of oral corticosteroids...
  3. doi request reprint The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada
    Cristina Varas-Lorenzo
    Pfizer, Global Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 18:1016-25. 2009
    ....
  4. pmc Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)
    Jordi Castellsague
    RTI Health Solutions, Barcelona, Spain
    Drug Saf 35:1127-46. 2012
    ....
  5. doi request reprint Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database
    Cristina Varas-Lorenzo
    RTI Health Solutions, Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 17:842-52. 2008
    ..Case definitions are essential to epidemiological research...
  6. doi request reprint Stroke risk and NSAIDs: a systematic review of observational studies
    Cristina Varas-Lorenzo
    RTI Health Solutions, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 20:1225-36. 2011
    ..To perform a quantitative systematic review of observational studies on the risk of stroke associated with the use of individual NSAIDs...
  7. ncbi request reprint Prevalence of glucose metabolism abnormalities and cardiovascular co-morbidity in the US elderly adult population
    Cristina Varas-Lorenzo
    Novartis Farmaceutica S A, Global Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 15:317-26. 2006
    ..To estimate the prevalence of glucose metabolism abnormalities, including diabetes, and its associated cardiovascular risk factors and co-morbidity in the US elderly population...
  8. ncbi request reprint Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction
    Sonia Hernandez-Diaz
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Basic Clin Pharmacol Toxicol 98:266-74. 2006
    ..There was a suggestion of a small increased risk with ibuprofen. Also, data suggest a small reduced risk for naproxen present only in non-users of aspirin, mainly people free of clinically apparent vascular disease...
  9. ncbi request reprint Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population
    Consuelo Huerta
    Centro Español de Investigación Farmacoepidemiológica, Spanish Centre for Pharmacoepidemiologic Research, Madrid, Spain
    Am J Kidney Dis 45:531-9. 2005
    ..Despite these studies, little is known about the effect of dose and duration of therapy, risk of individual NSAIDs, comorbidity, or concomitant use of other nephrotoxic drugs...
  10. ncbi request reprint Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population
    Luis A Garcia Rodriguez
    Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain
    Circulation 109:3000-6. 2004
    ..Some reports suggest that concurrent aspirin and ibuprofen might be associated with lower cardioprotection than aspirin alone because of a pharmacodynamic interaction...
  11. ncbi request reprint Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data
    Christianne L Roumie
    Veterans Administration, Tennessee Valley Healthcare System, Tennessee Valley Geriatric Research Education Clinical Center GRECC, Nashville, TN 37212, USA
    Pharmacoepidemiol Drug Saf 17:20-6. 2008
    ..To validate ICD 9 codes with a high positive predictive value (PPV) for incident strokes. The study population consisted of Tennessee Medicaid enrollees aged from 50 to 84 years...